pox virus CD40L vaccine (Therion)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namepox virus CD40L vaccine (Therion)

Drug Alias Nameanti-lymphoma recombinant fowl pox vaccine (Therion)CD40 costimulator (Therion)fowl pox vaccine encoding CD40L (Therion)anti-lymphoma rF-mCD40L (Therion)

ClassificationBiologics

Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonists

TargetsTumor necrosis factor receptor superfamily member 5

Therapy Area/IndicationsLymphoma, B-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTherion Biologics Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTherion Biologics Corp

Active IndicationsN/A

Inactive IndicationsLymphoma, B-Cell

Other Information

ATC CodeN/A